Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Coagulation disorders case study

Ofloxacin 200 mg daily for 7 days did not signifrcantly affect the prothrombin times of 7 healthy subjects stabilised on phenprocoumon. In a population-based cohort study, there were no cases of over-anticoagu-lation (USTR greater than 6) in patients taking acenocoumarol or phenprocoumon with ofloxacin (33 received ofloxacin. Note that this study did find an increased risk for norfloxacin, see (j) above. Furthermore, for the period December 1990 to January 2004, Health Canada had not received any reports of suspected coagulation disorders associated with ofloxacin and warfarin. ... [Pg.374]

See other pages where Coagulation disorders case study is mentioned: [Pg.1987]    [Pg.209]    [Pg.448]    [Pg.50]    [Pg.285]    [Pg.41]    [Pg.46]    [Pg.83]    [Pg.55]    [Pg.188]    [Pg.778]   
See also in sourсe #XX -- [ Pg.362 ]



SEARCH



Coagulation disorders

Coagulation studies

© 2024 chempedia.info